Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients.
Hecht M, Zimmer L, Loquai C, Weishaupt C, Gutzmer R, Schuster B, Gleisner S, Schulze B, Goldinger SM, Berking C, Forschner A, Clemens P, Grabenbauer G, Müller-Brenne T, Bauch J, Eich HT, Grabbe S, Schadendorf D, Schuler G, Keikavoussi P, Semrau S, Fietkau R, Distel LV, Heinzerling L.
Ann Oncol. 2015 Jun;26(6):1238-1244. doi: 10.1093/annonc/mdv139. Epub 2015 Mar 11.
[Folliculosebaceous cystic hamartoma: anatomo-clinical study].
Merklen-Djafri C, Batard ML, Guillaume JC, Kleinclauss I, Cribier B.
Ann Dermatol Venereol. 2012 Jan;139(1):23-30. doi: 10.1016/j.annder.2011.10.402. Epub 2011 Dec 6.
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.
Arnault JP, Mateus C, Escudier B, Tomasic G, Wechsler J, Hollville E, Soria JC, Malka D, Sarasin A, Larcher M, André J, Kamsu-Kom N, Boussemart L, Lacroix L, Spatz A, Eggermont AM, Druillennec S, Vagner S, Eychène A, Dumaz N, Robert C.
Clin Cancer Res. 2012 Jan 1;18(1):263-72. doi: 10.1158/1078-0432.CCR-11-1344. Epub 2011 Nov 17.
Cystic trichoblastoma (so-called trichoblastic infundibular cyst): a report of three new cases.
Juárez A, Rütten A, Kutzner H, Requena L.
J Cutan Pathol. 2012 Jun;39(6):631-6. doi: 10.1111/j.1600-0560.2012.01920.x. Epub 2012 May 11.
